<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4C654B02-8840-486B-A566-63DF0F710F63"><gtr:id>4C654B02-8840-486B-A566-63DF0F710F63</gtr:id><gtr:name>Antoine Beclere Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/659838E6-9600-4869-9BF5-071DB6E4F5BD"><gtr:id>659838E6-9600-4869-9BF5-071DB6E4F5BD</gtr:id><gtr:name>Robert Debre Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4C654B02-8840-486B-A566-63DF0F710F63"><gtr:id>4C654B02-8840-486B-A566-63DF0F710F63</gtr:id><gtr:name>Antoine Beclere Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/659838E6-9600-4869-9BF5-071DB6E4F5BD"><gtr:id>659838E6-9600-4869-9BF5-071DB6E4F5BD</gtr:id><gtr:name>Robert Debre Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C652E8DC-7B7C-4EEF-9E1D-1EC52538A11A"><gtr:id>C652E8DC-7B7C-4EEF-9E1D-1EC52538A11A</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_G1100158"><gtr:id>FF585BF7-913B-46DE-B9D9-9EE3914488EE</gtr:id><gtr:title>European study of Neonatal exposure to Excipients (ESNEE)/Priomedchild Call/ERA-Net</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_G1100158</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Excipents are chemicals added to medicines to improve their quality. Sporadic reports indicate that some may be toxic for neonates and lead to significant morbidity or death. However, there is insufficient information about the risks generated by excipient exposure because systematic surveys have not been done and studies on babies have not been ethical in the past. Recent advances allow determination of excipient levels in very small blood volumes (50 microlitre) including dry blood spot methods and estimates of excipient exposures based on only 2-4 samples per baby. Hypothesis 1: information about exposures across the EU will promote reduction of neonatal exposure to excipients by highlighting opportunities for product substitution and priorities for reformulation.|Hypothesis 2: small volume blood samples can be used to generate models of systemic excipient exposure. Our consortium comprises researchers from Estonia, France and the UK with extensive experience in all aspects of the study. We will develop a platform of techniques to assess excipient exposure including: a questionnaire and point prevalence study of neonatal excipient exposure; systematic reviews of relevant literature; dried blood spot assays for high impact excipients; a cohort study to construct population excipient kinetic models (EK, analogous to active drug pharmacokinetics or PK) for high impact excipients. This work will lead to recommendations for the European Medicines Agency and other stakeholders about assessment of excipient exposure and underpin future work to relate exposures to outcomes.|</gtr:technicalSummary><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>325115</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tartu</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>Tartu</gtr:description><gtr:id>D01D425C-1603-475D-AFAF-D7D8DF8CCD80</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:outcomeId>iibAFaVgwVJ-1</gtr:outcomeId><gtr:partnerContribution>Survey expertise</gtr:partnerContribution><gtr:piContribution>Clinical trials expertise; project management</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Leicester Medical School</gtr:department><gtr:description>Leicester</gtr:description><gtr:id>7912210D-D18D-4D08-9FD9-826C6ECBB393</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:outcomeId>gdvUCf2MZ6R-1</gtr:outcomeId><gtr:partnerContribution>Pharmacokinetic expertise, review of clinical materials</gtr:partnerContribution><gtr:piContribution>Expertise in clinical trials; project management</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Antoine Beclere Hospital</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Pharmacy Antoine Beclere Hospital</gtr:department><gtr:description>Paris 2</gtr:description><gtr:id>2FBA4D91-8D97-48C7-83F1-88B511A6CA36</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:outcomeId>V29W85WxDhF-1</gtr:outcomeId><gtr:partnerContribution>Pharmacy expertise</gtr:partnerContribution><gtr:piContribution>Clinical trials expertise; project management</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Robert Debre Hospital</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Paris</gtr:description><gtr:id>35995A05-9A6A-4BBF-8AB9-AF088CC7422D</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:outcomeId>ixy17HojbDS-1</gtr:outcomeId><gtr:partnerContribution>Expertise in literature review</gtr:partnerContribution><gtr:piContribution>Clinical trials expertise; project management</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Belfast</gtr:description><gtr:id>0DD5ED99-355E-4BF5-A961-72A0760A7269</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:outcomeId>oWYnn9tSq1b-1</gtr:outcomeId><gtr:partnerContribution>Assay expertise</gtr:partnerContribution><gtr:piContribution>Clinical trials expertise; project management</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Potentially harmful excipients in medicines - PPS - Estonia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DFBC4405-F376-42D6-9837-955F738C7EC5</gtr:id><gtr:impact>Nellis, G.; Lutsar, I.; Varendi, H.; Lass, J.; Turner, MT; Metsvaht, T. (2013). Potentially harmful excipients in medicines prescribed to European neonates - ESNEE PPS. 54th Annual Meeting of European Society of Paediatric Research, Porto, Oct 10-14, 2013.

Raising profile of study</gtr:impact><gtr:outcomeId>aHVAUqd28hE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>21st European Neonatology workshop</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4293742C-60C7-4072-84DA-39B9EF2A7F48</gtr:id><gtr:impact>Towards a systematic approach to risk assessment in neonates: a case study from the european study of neonatal exposure to excipients

Profile of study raised</gtr:impact><gtr:outcomeId>poDkQ4RnMBB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CI poster ESPR</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C4AA2C6-CCF9-4891-926E-B0F76793C8C2</gtr:id><gtr:impact>M.A. Turner, S. Yakkundi, T. Metsvah, H.Varendi, G. Nellis, J.Windrow, S.Graham, H.Mulla, H.Pandya, S.Tapscott, N.Caldwell, J.Duncan, I.Lutsar, T.Nunn, J.McElnay 2013. Methyl and propyl paraben concentrations in preterm neonates exposed to clincially indicated medicines fall within safety margins for oestrogenic effects of these anti-microbial excipients. 54th Annual meeting ESPR, Oct 10-14, 2013, Portugal

Findings from study with regards to safety margins of methyl &amp;amp; propyl concentrations in neonates</gtr:impact><gtr:outcomeId>ewTxBvvQ9CD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Journal Article with French Team</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BFB628F4-B5F7-4D6F-B7C6-EAAEF6722ECD</gtr:id><gtr:impact>Publication of ESNEE in the European Journal of Hospital Pharmacy to raise the profile of the ESNEE study throughout the European pharmacy community

The profile of the study was raised throughout Europe with many interested countries wishing to find out more information and to take part</gtr:impact><gtr:outcomeId>MQTmGVsabvx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Turner Poster</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E2D2C37C-92B3-4C91-8EDF-2F1C90435E0A</gtr:id><gtr:impact>Turner MA, Yakkundi S, Varendi H, Metsvaht T, Nellis G, Windrow J, Graham S, Mulla H, Pandya H, Tapscott S, Caldwell N, Duncan J, Lutsar I, McElnay J (2003). Methyl and propyl paraben concentrations in blood form preterm neonates exposed to clinically indicated medicines are lower than the concentrations of these anti-microbial excipients reported to affect cell physiology.

raising profile of study</gtr:impact><gtr:outcomeId>SK7rskhZHyd</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nellis Presentation UENPS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>28305394-8D4A-4D42-86DC-E53612968081</gtr:id><gtr:impact>Abstract (Potentially harmful excipient in antibiotics prescribed to European neonates - ESNEE survey) accepted at the 3rd international congress of UENPS. Nellis G et al. Oral Presentation

Raising profile of the study</gtr:impact><gtr:outcomeId>UHjwZXYoFYa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Uni of Tartu presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>47CE8EA0-68B9-4BA2-B92C-65E111D051A8</gtr:id><gtr:impact>Nellis G, Metsvaht T, Varendi H, Lass J, Turner M, Lutsar I
European study of neonatal excipient exposure (ESNEE): Preliminary results of the Point Prevalence Survey

Raising study profile</gtr:impact><gtr:outcomeId>hSPEqt3kfgj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Journal Article with Estonian Team</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A932A5AF-170A-4915-A3EB-C34700572820</gtr:id><gtr:impact>Publication of Hospitalised neonates in Estonia commonly receiving potentially harmful excipients in the BMC Pediatrics Journal

The publication raised the profile of the ESNEE study in Estonia and resulted in sites expressing a wish to take part in the project</gtr:impact><gtr:outcomeId>HJJKh2J8Zhp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nellis Poster Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A48F5CC2-30D7-4F15-8639-A88AB323AECB</gtr:id><gtr:impact>Antibiotic prescribing in European neonatal intensive care units: Service Evaluation Survey of the European Study of Neonatal Exposure to Excipients poster presentation at the 30th meeting of ESPID. The poster was read by other professionals and led to discussion of the project and work carried out

Interest in the study rose</gtr:impact><gtr:outcomeId>ePCfzstX8zZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dried Blood Spots Editorial</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2B6356A7-348C-4640-A11E-4E223B24534B</gtr:id><gtr:impact>An editorial about the use of dried blood spots to study experient kinetics in neonates was published in December 2011 .

Since this publication, there has been a lot of interest in the DBS excipient work. A couple of groups in the US and Mexico got in touch in order to discuss the paraben work.</gtr:impact><gtr:outcomeId>aAPLzLZ1ZG6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ethanol Concentrations poster</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8B076878-B4C6-48B0-BA99-1920A5AA367E</gtr:id><gtr:impact>Presentation at the 14th ESDPPP Congress, Salzburg 2013. M.Hubbard, R.Cordell, H.Pandya, P.Monks, M.A.Turner, H.Mulla. Circulating ethanol concentrations in neonates administered clinically indicicated medications: feasibility of microsampling methods as part of the european study of neonatal excipient exposure.

Raising profile of study specifically with regards to ethanol sampling</gtr:impact><gtr:outcomeId>HwA3vy4HX7P</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ESPID Estonia presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>952A7838-1C35-406A-B347-13EF9775D65F</gtr:id><gtr:impact>Metsvaht, T.; Nellis, G.; Varendi, H.; Graham, S.; Rieutord, A.; Storme, T.; Vaconsin, P.; Nunn, AJ.; McElnay, J.; Millership, J.; Yakkundi, S.; Mulla, H.; Pandya, H.; Turner, MA.; Lutsar, I. (2013). DOSING OF FREQUENTLY USED ANTIBIOTICS IN EUROPEAN NICUS: POINT PREVALENCE STUDY OF EUROPEAN STUDY OF NEONATAL EXPOSURE TO EXCIPENTS (ESNEE). In: 31th Annual Meeting of ESPID (European Society of Pediatric Infectious Diseases); Milan; 28.05.-01.06.2013

Raising profile</gtr:impact><gtr:outcomeId>mmbuupJN7RN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Potentially harmful excipients in antibiotics - Estonia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>813CBBAA-DC0E-40CE-BE18-F05314283ED6</gtr:id><gtr:impact>Potentially harmful excipients in antibiotics prescribed to european neonates - ESNEE survey. In: Acta M&amp;eacute;dica Portuguesa : 3rd International Congress of UENPS, 2012; Porto, nov 14-17. , 2012, (25; 2), 141. Nellis, Georgi; Varendi, Heili; Lass, Jana; Lutsar, Irja; Metsvaht, Tuuli

Discussion arose with regards to the presentation</gtr:impact><gtr:outcomeId>E3pZcQP4ipQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Belfast presentation USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F1E1B0C5-DEF2-49FB-B141-5858EF99DF48</gtr:id><gtr:impact>S. Yakkundi 2013. Application of LC-MS/MS to Determine the Exposure to Methyl and Propyl Parabens in Preterm Neonates using Dried Blood Spot (DBS)&amp;quot;,61ST ASMS Conference on Mass Spectrometry and Allied Topics, Minneapolis, USA, June 2013

Raising profile of study</gtr:impact><gtr:outcomeId>JW6sV5TxStb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Magazine article (Infant)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DF8287E2-D1B9-44DC-B724-24271D7C8274</gtr:id><gtr:impact>Magazine article targeted at health care professionals who would support clinical aspects of the project

Several new centres expressed an interest in participation, these centres are not part of our informal network of contacts</gtr:impact><gtr:outcomeId>CTY3bwRBmoi</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster Presentation (Belfast Team) (DBS to study excipient kinetics in neonates)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>46121B28-416C-4E2A-BFEE-9842443AA223</gtr:id><gtr:impact>An ESNEE poster regarding the Dried Blood Sports (DBS) analysis of excipients at the Reid Bioanalytical Forum, Guildford, 2011. The poster created a lot of interest as this is the first of its kind in DBS area.

The impact was that the ESNEE team were asked to submit an editorial for the Journal</gtr:impact><gtr:outcomeId>nh2hPqXt8oT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Estonia Presentation  blood concs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DED03B6D-AEBB-4565-99CF-334B11C98280</gtr:id><gtr:impact>Nellis, G.; Lutsar, I.; Varendi, H.; Turner, MA.; Graham, S.; Rieutord, A.; Storme, T.; Vaconsin, P.; Nunn, AJ.; McElnay, J.; Millership, J.; Yakkundi, S.; Mulla, H.; Pandya, H.; Metsvaht, T. (2013). BLOOD CONCENTRATIONS OF METHYL AND PROPYL PARABENS IN NEONATES TREATED WITH GENTAMICIN AS THE MOST COMMONLY USED ANTIBIOTIC. 31th Annual meeting of ESPID (European Society of Pediatric Infectious Diseases) Milan, Italy; 28.05.-01.06.2013.

Raising profile of study</gtr:impact><gtr:outcomeId>eqRwBwTwEy9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Probiotics Estonian presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A27F5F09-904A-4AE6-BAC0-BA2E55F1F6B7</gtr:id><gtr:impact>Moor, R.; Metsvaht, T; Nellis, G.; Varendi, H.; Lutsar, I. (2013). The use of probiotics in European neonatal intensive care units: sub-analysis of the ESNEE point prevalence study. 2nd Baltic Pediatric Congress; P&amp;auml;rnu 30.05.-01.06.2013.

Raised discussion about the work carried out for project</gtr:impact><gtr:outcomeId>to4TXuSVpxZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ESNEE - Estonian presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8EDC017B-1118-4976-8841-2625D40AB4D0</gtr:id><gtr:impact>Nellis, G.; Varendi, H.; Metsvaht, T.; Lutsar, I. (2012). Medicines used for neonates in Europe - the survey of the European study of neonatal exposure to excipients (ESNEE). In: Journal of Neonatal-Perinatal Medicine: 20th European Workshop on Neonatology, Tallinn, 27th - 30th June, 2012. IOS Press, 2012, (5; 2), 199.

Discussion arose around the subject area &amp;amp; study</gtr:impact><gtr:outcomeId>ACAbFytqdY3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Probiotic use PPS - Estonia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6A674B2C-AA02-4D6F-8997-CACF6C89097D</gtr:id><gtr:impact>Metsvaht, T.; Moor, R.; Nellis, G.; Varendi, H.; Lutsar, I. (2013). PROBIOTIC (PB) USE IN RELATION TO ANTIBIOTIC (AB) USE IN EUROPEAN NEONATAL INTENSIVE CARE UNITS (NICU): SUB-ANALYSIS OF ESNEE POINT PREVALENCE STUDY (PPS). 8th World Congress of the World Society for Pediatric Infectious Diseases; Capetown, South Africa; 20.-23. November 2013.

Raising profile of study</gtr:impact><gtr:outcomeId>c4EyxiYbAEp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Interaction with European Medicines Agency</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>6F2E1F80-175F-45DB-8250-D35757A6FCF6</gtr:id><gtr:outcomeId>FWKJ9zhHsx2</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Excipients are widely used in medicines given to neonates but their circulating concentrations have never been evaluated.</gtr:description><gtr:id>BB7E077F-3284-4582-94C1-C3BB11278193</gtr:id><gtr:impact>Our study of excipient kinetics examined three excipients. This is the first time this has been done in neonates. The use of dried blood spots was novel.
The results have been published and presented to the regulatory authorities.</gtr:impact><gtr:outcomeId>5464c86c8891a3.09995710</gtr:outcomeId><gtr:status>Closed</gtr:status><gtr:title>Clinical study of excipient kinetics</gtr:title><gtr:type>Management of Diseases and Conditions</gtr:type><gtr:ukcrnIsctnId>ISRCTN  31837223</gtr:ukcrnIsctnId><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The Pharmacy Department at Leicester have developed an assay for ethanol and 3 of its metabolites from microsamples of plasma (50 micro litres)</gtr:description><gtr:id>DFA03B7B-DE0C-4C84-924D-E9446A10FBB8</gtr:id><gtr:impact>This assay is being applied to 150 samples from 50 babies recruited to the clinical study.</gtr:impact><gtr:outcomeId>hdiJxiXFKuN</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Assay development, ethanol</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Assays for parabens in whole blood samples collected in dried blood spots have been developed by the Pharmacy Dept at Queens University Belfast</gtr:description><gtr:id>BBA803D2-E4F7-4BA0-81EC-9ECF0F24EBCB</gtr:id><gtr:impact>Assays are currently being applied to 500 samples from 150 babies recruited in our clinical studies</gtr:impact><gtr:outcomeId>XceWuVteNGQ</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Assay development</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>999C3E0A-F890-462A-ABFF-F3F7D6ED352B</gtr:id><gtr:title>Potentially Harmful Excipients in Antibiotics Prescribed to European Neonates - ESNEE Survey</gtr:title><gtr:parentPublicationTitle>Acta M?dica Portuguesa : 3rd International Congress of UENPS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a10e66736cfe3538e886d31e194705f"><gtr:id>6a10e66736cfe3538e886d31e194705f</gtr:id><gtr:otherNames>Nellis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>5464dc5e71df23.06531243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9D92871-DAB3-42A8-B389-2870C2CF4171</gtr:id><gtr:title>Use of dried blood spots to study excipient kinetics in neonates.</gtr:title><gtr:parentPublicationTitle>Bioanalysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b67b482553450261ff9d00cf93a10a6"><gtr:id>6b67b482553450261ff9d00cf93a10a6</gtr:id><gtr:otherNames>Yakkundi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-6180</gtr:issn><gtr:outcomeId>pm_14359_29_22185265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E423FE33-21F9-4E32-83C2-362473028356</gtr:id><gtr:title>Medicines used for neonates in Europe - the survey of the European study of neonatal exposure to excipients (ESNEE).</gtr:title><gtr:parentPublicationTitle>Journal of Neonatal-Perinatal Medicine: 20th European Workshop on Neonatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a10e66736cfe3538e886d31e194705f"><gtr:id>6a10e66736cfe3538e886d31e194705f</gtr:id><gtr:otherNames>Nellis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>5464dba25190d8.12301638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A565DD25-3271-43BE-8FA3-42500D89CF57</gtr:id><gtr:title>An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates.</gtr:title><gtr:parentPublicationTitle>Pharmaceutical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b6b8688a694ed1c9ff876103cfb244b"><gtr:id>9b6b8688a694ed1c9ff876103cfb244b</gtr:id><gtr:otherNames>Mulla H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0724-8741</gtr:issn><gtr:outcomeId>5464c5b4e7b734.73440812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>619EFF9E-9930-443E-90B9-876B104852F6</gtr:id><gtr:title>Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97c3228c7e6bdf78b083d1cfbc2d2d9b"><gtr:id>97c3228c7e6bdf78b083d1cfbc2d2d9b</gtr:id><gtr:otherNames>Turner MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn><gtr:outcomeId>5464d5eb7d92d4.83466243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3975506E-33A9-4EC4-BB63-11B93F715825</gtr:id><gtr:title>European Study of Neonatal Exposure to Excipients: an update.</gtr:title><gtr:parentPublicationTitle>International journal of pharmaceutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97c3228c7e6bdf78b083d1cfbc2d2d9b"><gtr:id>97c3228c7e6bdf78b083d1cfbc2d2d9b</gtr:id><gtr:otherNames>Turner MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0378-5173</gtr:issn><gtr:outcomeId>5464de0d1c07a7.63959030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>918A8066-E46D-4A99-BCC3-695027AC933D</gtr:id><gtr:title>Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.</gtr:title><gtr:parentPublicationTitle>Paediatric drugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a10e66736cfe3538e886d31e194705f"><gtr:id>6a10e66736cfe3538e886d31e194705f</gtr:id><gtr:otherNames>Nellis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1174-5878</gtr:issn><gtr:outcomeId>58ca8761c340a1.64190215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02183E1-8B37-484B-8275-D1F5966CEAEF</gtr:id><gtr:title>Why are Excipients Important to Neonates?</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97c3228c7e6bdf78b083d1cfbc2d2d9b"><gtr:id>97c3228c7e6bdf78b083d1cfbc2d2d9b</gtr:id><gtr:otherNames>Turner MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>56e12ef50c3e11.84417700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AABFB239-AC23-47C9-A75E-1BAB3DDC2D3A</gtr:id><gtr:title>Potentially harmful excipients in neonatal medicines: a pan-European observational study.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a10e66736cfe3538e886d31e194705f"><gtr:id>6a10e66736cfe3538e886d31e194705f</gtr:id><gtr:otherNames>Nellis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>56e12ef4d78a06.21168804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FAC3168-4749-4AB2-B9B5-61C05F2158E4</gtr:id><gtr:title>High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination.</gtr:title><gtr:parentPublicationTitle>BMC pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fee1c431dbce128cf4bcc4c7ce399346"><gtr:id>fee1c431dbce128cf4bcc4c7ce399346</gtr:id><gtr:otherNames>Metsvaht T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2431</gtr:issn><gtr:outcomeId>58ca8761671331.60471662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71272C49-C32C-4E13-98D7-E1D3812D2EB5</gtr:id><gtr:title>Hospitalised neonates in Estonia commonly receive potentially harmful excipients.</gtr:title><gtr:parentPublicationTitle>BMC pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6afd54821d7669d22d933a136252ff85"><gtr:id>6afd54821d7669d22d933a136252ff85</gtr:id><gtr:otherNames>Lass J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2431</gtr:issn><gtr:outcomeId>STf4wPZAb4W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>163AA1A7-F0B2-4CAE-B800-DF4B5F27A7BA</gtr:id><gtr:title>Comparison of two alternative study designs in assessment of medicines utilisation in neonates.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a10e66736cfe3538e886d31e194705f"><gtr:id>6a10e66736cfe3538e886d31e194705f</gtr:id><gtr:otherNames>Nellis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>5464dcf205c255.20211525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C6D88DF-99F2-4F54-AC97-8907AF2444C1</gtr:id><gtr:title>Neonatal drug development.</gtr:title><gtr:parentPublicationTitle>Early human development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97c3228c7e6bdf78b083d1cfbc2d2d9b"><gtr:id>97c3228c7e6bdf78b083d1cfbc2d2d9b</gtr:id><gtr:otherNames>Turner MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0378-3782</gtr:issn><gtr:outcomeId>pm_14359_29_21925812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>441A79E2-F1B7-46C8-BAF8-96B4128BFA74</gtr:id><gtr:title>Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates.</gtr:title><gtr:parentPublicationTitle>European journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/511a033c5c393f5bb444b1e0763a472e"><gtr:id>511a033c5c393f5bb444b1e0763a472e</gtr:id><gtr:otherNames>Pandya HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-6199</gtr:issn><gtr:outcomeId>58ca87619a07c5.94288607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DFD713E-7EFE-4974-B88E-A936F9C50F9C</gtr:id><gtr:title>Quantitative analysis of methyl and propyl parabens in neonatal DBS using LC-MS/MS.</gtr:title><gtr:parentPublicationTitle>Bioanalysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b67b482553450261ff9d00cf93a10a6"><gtr:id>6b67b482553450261ff9d00cf93a10a6</gtr:id><gtr:otherNames>Yakkundi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1757-6180</gtr:issn><gtr:outcomeId>58ca8761ef2e28.89092555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42342942-6A01-4EA4-99BB-20756568AEB0</gtr:id><gtr:title>Ethanol in oral liquid iron and furosemide formulations is incompletely metabolised by neonates</gtr:title><gtr:parentPublicationTitle>European Journal of Pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/511a033c5c393f5bb444b1e0763a472e"><gtr:id>511a033c5c393f5bb444b1e0763a472e</gtr:id><gtr:otherNames>Pandya HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56e13088a9a520.72174286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FEA9E75-90A4-4A6D-B0C1-0C0E8030C17E</gtr:id><gtr:title>European Study for Neonatal Excipient Exposure (ESNEE)</gtr:title><gtr:parentPublicationTitle>European Journal of Hospital Pharmacy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6908988a9a607232738eabea8393d78"><gtr:id>d6908988a9a607232738eabea8393d78</gtr:id><gtr:otherNames>Turner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>PJkKTsQU53c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C66B8033-7B4A-4A40-A2F7-CCA64C8A327B</gtr:id><gtr:title>European Study of Neonatal Exposure to Excipients (ESNEE)</gtr:title><gtr:parentPublicationTitle>Infant</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60f17183ef42fdff66f43bce935f7da6"><gtr:id>60f17183ef42fdff66f43bce935f7da6</gtr:id><gtr:otherNames>Graham Susan</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>i9K6ioYZcz1</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_G1100158</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>